Home Intabio

Intabio

acquired
Series B
Developer of Biopharmaceutical Analysis Systems
Basic
Enterprise Profile

Basic Information

Intabio, Inc. is a Silicon Valley-based company developing analytical solutions to transform the development and manufacturing of biotherapeutics, offering early product quality characterization and significant efficiency gains across all stages of biopharmaceutical development and manufacturing. Intabio's first product, the Blaze system, is a microchip-based instrument system capable of rapidly detecting and identifying subtle protein modifications—modifications that may disrupt the stability and efficacy of biotherapeutic drugs such as monoclonal antibodies and recombinant proteins.
Intabio, Inc.
California,United States of America
less than 15 people
January 01, 2015
info@intabio.com

Enterprise Profile

Industrial Sector
Drug-Related Drug Trial Big Data Analytics Services
Technology
Gene Technology Biotechnology
Application Scenarios
Smart Healthcare Drug Concepts Big Data